Index -
P/E 304.80
EPS (ttm) 0.40
Insider Own 6.13%
Shs Outstand 93.73M
Perf Week -5.99%
Market Cap 11.76B
Forward P/E 10.99
EPS next Y 11.22
Insider Trans -0.40%
Shs Float 89.52M
Perf Month 3.81%
Income 47.30M
PEG -
EPS next Q -0.06
Inst Own 92.37%
Short Float 6.32%
Perf Quarter -12.34%
Sales 1.50B
P/S 7.81
EPS this Y 135.17%
Inst Trans 6.88%
Short Ratio 6.26
Perf Half Y -7.76%
Book/sh 11.30
P/B 10.91
EPS next Y 450.20%
ROA 1.44%
Short Interest 5.66M
Perf Year 61.12%
Cash/sh 15.31
P/C 8.05
EPS next 5Y -
ROE 5.20%
52W Range 68.00 - 173.25
Perf YTD 27.85%
Dividend Est. -
P/FCF -
EPS past 5Y -1.21%
ROI 2.01%
52W High -28.84%
Beta 0.80
Dividend TTM -
Quick Ratio 3.19
Sales past 5Y 32.89%
Gross Margin 85.64%
52W Low 81.31%
ATR (14) 3.32
Dividend Ex-Date -
Current Ratio 3.90
EPS Y/Y TTM 104.65%
Oper. Margin 2.52%
RSI (14) 41.53
Volatility 2.37% 2.70%
Employees 1314
Debt/Eq 1.27
Sales Y/Y TTM 49.98%
Profit Margin 3.14%
Recom 1.27
Target Price 192.05
Option/Short Yes / Yes
LT Debt/Eq 1.19
EPS Q/Q 125.32%
Payout -
Rel Volume 1.26
Prev Close 126.00
Sales Surprise -7.98%
EPS Surprise 154.05%
Sales Q/Q 38.93%
Earnings Nov 06 AMC
Avg Volume 903.61K
Price 123.29
SMA20 -1.92%
SMA50 -3.31%
SMA200 -5.55%
Trades
Volume 1,140,419
Change -2.15%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-21-24 Initiated
Jefferies
Buy
$165
Oct-10-24 Resumed
Raymond James
Outperform
$150
Jul-29-24 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$182
Jun-26-24 Downgrade
Citigroup
Buy → Neutral
$172 → $176
May-31-24 Initiated
Piper Sandler
Overweight
$157
May-28-24 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$157 → $142
May-14-24 Upgrade
Oppenheimer
Perform → Outperform
$180
Jan-31-24 Initiated
BMO Capital Markets
Outperform
$170
Dec-13-23 Resumed
Citigroup
Buy
$113
Dec-12-23 Initiated
Deutsche Bank
Buy
$109
Nov-21-23 Initiated
Wedbush
Outperform
$224
Oct-31-23 Downgrade
Oppenheimer
Outperform → Perform
Oct-31-23 Downgrade
Cantor Fitzgerald
Overweight → Neutral
$166 → $40
Jun-23-23 Downgrade
Evercore ISI
Outperform → In-line
$139
Apr-26-23 Initiated
SMBC Nikko
Outperform
$185
Apr-04-23 Initiated
Citigroup
Buy
$179
Mar-01-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$141 → $187
Dec-22-22 Reiterated
BTIG Research
Buy
$125 → $160
Dec-16-22 Upgrade
UBS
Neutral → Buy
$100 → $158
Apr-04-22 Resumed
Cantor Fitzgerald
Overweight
$140
Show Previous Ratings
Oct-31-24 04:10PM
Oct-27-24 09:07AM
Oct-23-24 08:30AM
Oct-18-24 08:00AM
(Investor's Business Daily)
Oct-17-24 09:53AM
04:02PM
Loading…
Oct-16-24 04:02PM
Oct-03-24 08:15AM
Sep-30-24 04:39PM
12:38PM
Sep-26-24 08:30AM
Sep-21-24 10:10AM
Sep-19-24 08:30AM
Sep-16-24 08:30AM
Sep-14-24 07:27PM
Sep-13-24 06:45AM
02:00AM
Loading…
Sep-08-24 02:00AM
Sep-06-24 11:31AM
Sep-05-24 09:00AM
Sep-03-24 12:37PM
Aug-30-24 04:10PM
08:53AM
08:30AM
Aug-20-24 02:30PM
(The Wall Street Journal)
Aug-19-24 07:00AM
(The Wall Street Journal)
Aug-12-24 09:30AM
Aug-09-24 04:17PM
(Investor's Business Daily) -8.11%
09:35AM
Aug-08-24 01:36PM
(Thomson Reuters StreetEvents)
07:50AM
12:30AM
06:00PM
Loading…
Aug-07-24 06:00PM
04:28PM
04:17PM
(Associated Press Finance)
04:05PM
Aug-05-24 12:00PM
Aug-01-24 10:01AM
Jul-31-24 04:15PM
Jul-29-24 07:00AM
Jul-21-24 06:59AM
Jul-19-24 09:55AM
Jul-17-24 08:00AM
Jul-16-24 12:00PM
Jul-08-24 12:04PM
Jul-06-24 08:00AM
Jul-04-24 06:35AM
Jul-03-24 10:05AM
Jun-28-24 06:30PM
Jun-26-24 10:06AM
03:45AM
Jun-24-24 02:55PM
(Investor's Business Daily)
03:49AM
Jun-21-24 05:25PM
(Yahoo Finance Video) +30.14%
05:05PM
04:28PM
(Investor's Business Daily)
04:23PM
02:39PM
01:53PM
(The Wall Street Journal)
01:00PM
12:58PM
12:48PM
12:29PM
(Investor's Business Daily)
12:14PM
(The Wall Street Journal)
11:24AM
11:09AM
11:00AM
(The Wall Street Journal)
10:42AM
09:32AM
09:31AM
09:14AM
08:42AM
07:52AM
07:34AM
06:40AM
(Investor's Business Daily)
Jun-20-24 05:02PM
02:13PM
01:22PM
Jun-13-24 04:04PM
(Investor's Business Daily)
01:07PM
07:00AM
Jun-06-24 07:00AM
May-31-24 05:45PM
11:31AM
May-29-24 05:48PM
08:28AM
May-28-24 10:52PM
May-24-24 11:57AM
May-23-24 07:10AM
May-17-24 08:05AM
May-14-24 07:30AM
May-04-24 12:00PM
May-03-24 10:07AM
May-02-24 03:42PM
11:30AM
11:13AM
11:08AM
07:52AM
06:01AM
(Thomson Reuters StreetEvents)
03:32AM
May-01-24 08:55PM
07:30PM
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Estepan Ian Michael Chief Financial Officer Aug 30 '24 Sale 137.36 5,985 822,100 33,946 Sep 03 08:00 PM Estepan Ian Michael Officer Aug 30 '24 Proposed Sale 137.37 5,985 822,130 Aug 30 05:03 PM Chambers Michael Andrew Director Aug 16 '24 Buy 133.80 37,038 4,955,728 284,034 Aug 20 08:00 AM BEHRENS M KATHLEEN Director Jul 03 '24 Option Exercise 13.90 15,000 208,500 191,839 Jul 08 08:00 PM Brown Ryan Edward EVP, General Counsel Jun 25 '24 Option Exercise 62.77 23,500 1,475,095 56,086 Jun 25 08:00 PM Brown Ryan Edward EVP, General Counsel Jun 25 '24 Sale 161.61 38,957 6,296,029 17,129 Jun 25 08:00 PM Arif Bilal Chief Tech Ops Officer Jun 24 '24 Sale 163.08 7,859 1,281,621 21,261 Jun 25 08:00 PM Arif Bilal Chief Tech Ops Officer Jun 25 '24 Sale 163.23 3,898 636,271 17,363 Jun 25 08:00 PM Murray Dallan Chief Customer Officer May 02 '24 Sale 140.00 3,635 508,900 18,125 May 06 08:09 PM Wigzell Hans Lennart Rudolf Director Mar 08 '24 Option Exercise 13.90 15,000 208,500 37,840 Mar 11 08:02 PM Wigzell Hans Lennart Rudolf Director Mar 08 '24 Sale 123.25 15,000 1,848,795 22,840 Mar 11 08:02 PM Boor Kathryn Jean Director Mar 11 '24 Sale 122.93 761 93,550 7,516 Mar 11 08:00 PM Mayo Stephen Director Mar 05 '24 Sale 122.96 3,135 385,480 6,621 Mar 06 08:00 PM Arif Bilal Chief Tech Ops Officer Mar 01 '24 Sale 128.84 2,000 257,676 26,836 Mar 05 08:00 PM Estepan Ian Michael Chief Financial Officer Mar 01 '24 Sale 128.30 1,200 153,960 39,114 Mar 05 08:00 PM Brown Ryan Edward EVP, General Counsel Mar 01 '24 Sale 125.34 2,000 250,680 31,827 Mar 05 08:00 PM Barry Richard Director Nov 03 '23 Buy 78.81 50,000 3,940,500 140,000 Nov 06 08:00 AM INGRAM DOUGLAS S President & CEO Nov 03 '23 Buy 79.36 25,225 2,001,800 390,307 Nov 06 08:00 AM BEHRENS M KATHLEEN Director Nov 03 '23 Option Exercise 29.03 15,000 435,450 174,993 Nov 06 08:00 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite